Systemic and local interferon γ gene delivery to the lungs for treatment of allergen-induced airway hyperresponsiveness in mice

Human Gene Therapy

Volumn 10, Issue 12, 1999, Pages 1905-1914

  Dow, Steven W ^a,b   Şchwarze, Jürgen ^a   Heath, Timothy D ^c   Potter, Terry A ^a,b   Gelfand, Erwin W ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; OVALBUMIN; RECOMBINANT INTERLEUKIN 12;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; EOSINOPHILIA; GENE TARGETING; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; MOUSE; NONHUMAN; PROVOCATION TEST; SENSITIZATION;

ALLERGENS; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; CYTOKINES; DISEASE MODELS, ANIMAL; EOSINOPHILIA; FEMALE; GENE THERAPY; IMMUNOGLOBULIN E; INTERFERON TYPE II; LIPOSOMES; LUNG; MICE; MICE, INBRED BALB C; OVALBUMIN; TRACHEA;

ANIMALIA; RODENTIA;

EID: 0033543072     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950017266     Document Type: Article

References (31)

1. BRAUN, C.M., HUANG, S-.K., BASHIAN, G.G., KAGEY-SOBOTKA, A., LICHTEN STEIN, L.M., and ESSAYAN, D.M. (1997). Corticosteroid modulation of human, antigen-specific Th1 and Th2 responses. J. Allergy Clin. Immunol. 100, 400-407.
2. CDC (CENTERS FOR DISEASE CONTROL and PREVENTION). (1996). Asthma mortality and hospitalization among children and young adults - United States, 1990-1993. MMWR 45, 350-353.
3. COOKSON, W.O.C.M., and MOFFATT, M.F. (1998). Alchemy for asthma. Nature Med. 4, 500-501.
4. DOW, S.W., LIGGITT, D.H., FRADKIN, L.G., WILLSON, A.P., HEATH, T.D., and POTTER, T.A. (1999). Lipid-DNA complexes induce potent activation of innate immune responses when injected intravenously. J. Immunol. (in press).
5. EASTMAN, S.J., TOUSIGNANT, J.D., LUKASON, M.J., CHU, Q., CHENG, S.H., and SCHEULE, R.K. (1998). Aerosolization of cationic lipid-DNA complexes - in vitro optimization of nebulizer parameters for human clinical studies. Hum. Gene Ther. 9, 43-52.
6. FREIMARK, B.D., BLEZINGER, H.P., FLORACK, V.J., NORDSTROM, J.L., LONG, S.D., DESHPANDE, D.S., NOCHUMSON, S., and PETRAK, K.L. (1998). Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: Cationic lipid complexes. J. Immunol. 160, 4580-4586.
7. GAVETT, S.H., O'HEARN, D.J., LI, X., HUANG, S., FINKELMAN, F.D., and WILLS-KARP, M. (1995). Interleukin-12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182, 1527-1536.
8. GELFAND, E.W., and IRVIN, C.G. (1997). T lymphocytes: Setting the tone of the airways. Nature Med. 3, 382-383.
9. GORMAN, C.M., AIKAWA, M., FOX, B., FOX, E., LAPUZ, C., MICHAUD, B., NGUYEN, H., ROCHE, E., SAWA, T., and WIENER-KRONISH, J.P. (1997). Efficient in vivo delivery of DNA to pulmonary cells using the novel lipid EDMPC. Gene Ther. 4, 983-992.
10. HAMELMANN, E., OSHIBA, A., PALUH, J., BRADLEY, K., LOADER, J., POTTER, T.A., LARSEN, G.L., and GELFAND, E.W. (1996). Requirement for CD8+ T cells in the development of airway hyperresponsivenes in a marine model of airway sensitization. J. Exp. Med. 183, 1719-1729.
11. HAMELMANN, E., SCHWARZE, J., TAKEDA, K., OSHIBA, A., LARSEN, G.L., IRVIN, C.G., and GELFAND, E.W. (1997). Non-invasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care Med. 156, 766-772.
12. HOGAN, S.P., FOSTER, P.S., TAN, X., and RAMSAY, A.J. (1998a). Mucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity. Eur. J. Immunol. 28, 413-423.
13. HOGAN, S.P., KOSKINEN, A., MATTHAEI, K.I., YOUNG, I.G., and FOSTER, P.S. (1998b). Interleukin-5 producing CD4+ T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice. Am. J. Crit. Care Med. 157, 210-218.
14. JIANG, C., O'CONNOR, S.P., FANG, S.L., WANG, K.X., MARSHALL, J., WILLIAMS, J.L., WILBURN, B., ECHELARD, Y., and CHENG, S.H. (1998). Efficiency of cationic lipid-mediated transfection of polarized and differentiated airway epithelial cells in vitro and in vivo. Hum. Gene Ther. 9, 1531-1542.
15. KNOWLES, M.R., HOHNEKER, K.W., ZHOU, Z., OLSEN, J.C., NOAH, T.L., HU, P.C., LEIGH, M.W., ENGLEHARDT, J.F., EDWARDS, L.J., JONES, K.R., and BOUCHER, R. (1995). A controlled study of adenoviral-vector-mediated gene transfer in nasal epithelium of patients with cystic fibrosis. N. Engl. J. Med. 333, 823-831.
16. LACK, G., RENZ, H., SALOGA, J., BRADLEY, K., LOADER, J., LEUNG, D.Y.M., and GELFAND, E.W. (1994). Nebulized but not parenteral IFN-γ decreases IgE production and normalizes airway function in a murine model of allergen sensitization. J. Immunol. 152, 2546-2554.
17. LI, X., CHOPRA, R.K., CHOU, T., SCHOFIELD, B.H., WILLSKARP, M., and HUANG, S. (1996). Mucosal IFN-γ gene transfer inhibits pulmonary allergic responses in mice. J. Immunol. 157, 3216-3219.
18. LIU, Y., LIGGITT, D., TU, G., ZHONG, W., GNESLER, K., and DEBS, R. (1995). Cationic lipsome-mediated intravenous gene delivery in mice. J. Biol. Chem. 27, 24864-24870.
19. LIU, Y., MOUNKES, L.C., LIGGITT, H.D., BROWN, C.S., SOLODIN, I., HEATH, T.D., and DEBS, R.J. (1997). Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nature Biotechnol. 15, 167-173.
20. MCDONALD, R.J., LIGGITT, D., ROCHE, L., NGUYEN, H.T., PEARLMAN, R., RAABE, O.G., BUSSEY, L.B., and GORMAN, C.M. (1998). Aerosol delivery of lipid-DNA complexes to lungs of rhesus monkeys. Pharm. Res. 15, 671-679.
21. NATIONAL ASTHMA EDUCATION AND PREVENTION PROGRAM. (1997). Expert panel report 2: Guidelines for the diagnosis and management of asthma. Publication no. 97-4051. National Institutes of Health, Bethesda, MD.
22. OSHIBA, A., HAMELMANN, E., TAKEDA, K., BRADLEY, K., LOADER, I.E., LARSEN, G.L., and GELFAND, E.W. (1996). Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice. J. Clin. Invest. 97, 1398-1408.
23. ROBINSON, D.S., HAMID, Q., YING, S., TSICOPOULOS, A., BARKANS, J., BENTLEY, A.M., CORRIGAN, C.J., DURHAM, S.R., and KAY, A.B. (1992). Predominant Th2-like T lymphocyte populations in atopic asthma. N. Engl. J. Med. 326, 298-302.
24. SCHLEIMER, R.P. (1993). An overview of glucocorticoid anti-inflammatory actions. Eur. J. Clin. Pharmacol. 45, 3-7.
25. SCHUMACHER, J.H., O'GARRA, A., SHRADER, B., VAN KIMMENADE, A., BOND, M.W., MOSMANN, T.R., and COFFMAN, R.L. (1988). The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent assay. J. Immunol. 141, 1576-1583.
26. SCHWARZE, J., HAMELMANN, E., CIESLEWICZ, G., TOMKINSON, A., JOETHAM, A., BRADLEY, K., and GELFAND, E.W. (1998). Local treatment with IL-12 is an effective inhibitor of airway hyperresponsiveness and lung eosinophilia after airway challenge in sensitized mice. J. Allergy Clin. Immunol. 102, 86-93.
27. SOLODIN, I., BROWN, C., BRUNO, M., CHOW, C., JANG, E.-H., DEBS, R., and HEATH, T. (1995). High efficiency in vivo gene delivery with a novel series of amphilic imadazolinium compounds. Biochemistry 34, 13537-13544.
28. SONG, Y.K., LIU, F., CHU, S., and LIU, D. (1997). Characterization of cationic-liposome-mediated gene transfer in vivo by intravenous administration. Hum. Gene Ther. 8, 1585-1594.
29. TEMPLETON, N.S., LASIC, D.D., FREDERICK, P.M., STREY, H.H., ROBERTS, D.D., and PAVLAKIS, G.N. (1997). Improved DNA-liposome complexes for increased systemic delivery and gene expression. Nature Biotechnol. 15, 647-652.
30. WALKER, C., BODE, E., BOER, L., HANSEL, T.T., BLASER, K., and VIRCHOW, J.C., Jr. (1992). Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Respir. Dis. 146, 109-115.
31. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., GONCZOL, E., and WILSON, J.M. (1994). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. U.S.A. 91, 4407-4411.